These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16363663)

  • 1. [The immunoregulatory role of local antigen-presenting cells in ocular inflammation].
    Sonoda KH
    Nippon Ganka Gakkai Zasshi; 2005 Nov; 109(11):700-7. PubMed ID: 16363663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis.
    Sonoda KH; Sasa Y; Qiao H; Tsutsumi C; Hisatomi T; Komiyama S; Kubota T; Sakamoto T; Kawano Y; Ishibashi T
    J Immunol; 2003 Sep; 171(5):2652-9. PubMed ID: 12928419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of systemic tolerance elicited by antigen inoculation into the vitreous cavity: vitreous cavity-associated immune deviation.
    Sonoda KH; Sakamoto T; Qiao H; Hisatomi T; Oshima T; Tsutsumi-Miyahara C; Exley M; Balk SP; Taniguchi M; Ishibashi T
    Immunology; 2005 Nov; 116(3):390-9. PubMed ID: 16236129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of experimental ocular inflammation on ocular immune privilege.
    Ohta K; Wiggert B; Taylor AW; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2010-8. PubMed ID: 10440255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
    Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
    Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intraocular inflammation and homeostasis of the eye].
    Mochizuki M
    Nippon Ganka Gakkai Zasshi; 2009 Mar; 113(3):344-77; discussion 378. PubMed ID: 19348183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible immune regulation following autoimmune disease in the immune-privileged eye.
    Kitaichi N; Namba K; Taylor AW
    J Leukoc Biol; 2005 Apr; 77(4):496-502. PubMed ID: 15647326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental autoimmune uveoretinitis (EAU)-related tissue damage and angiogenesis is reduced in CCL2⁻/⁻CX₃CR1gfp/gfp mice.
    Zhao J; Chen M; Xu H
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(11):7572-82. PubMed ID: 25342612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis.
    Crane IJ; McKillop-Smith S; Wallace CA; Lamont GR; Forrester JV
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1547-52. PubMed ID: 11381059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.
    Lipski DA; Dewispelaere R; Foucart V; Caspers LE; Defrance M; Bruyns C; Willermain F
    J Neuroinflammation; 2017 Jul; 14(1):136. PubMed ID: 28720143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressor role of rat CD8+CD45RClow T cells in experimental autoimmune uveitis (EAU).
    Han G; Shao H; Peng Y; Zhang P; Ke Y; Kaplan HJ; Sun D
    J Neuroimmunol; 2007 Feb; 183(1-2):81-8. PubMed ID: 17196261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory processes triggered by TCR engagement or by local cytokine expression: differences in profiles of gene expression and infiltrating cell populations.
    Takase H; Yu CR; Ham DI; Chan CC; Chen J; Vistica BP; Wawrousek EF; Durum SK; Egwuagu CE; Gery I
    J Leukoc Biol; 2006 Sep; 80(3):538-45. PubMed ID: 16793919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of an in vitro-generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye.
    Hara Y; Caspi RR; Wiggert B; Dorf M; Streilein JW
    J Immunol; 1992 Sep; 149(5):1531-8. PubMed ID: 1387141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WSX-1 plays a significant role for the initiation of experimental autoimmune uveitis.
    Sonoda KH; Yoshimura T; Takeda A; Ishibashi T; Hamano S; Yoshida H
    Int Immunol; 2007 Jan; 19(1):93-8. PubMed ID: 17118967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
    Hara Y; Okamoto S; Rouse B; Streilein JW
    J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of immune privilege in eyes with Mycobacteria tuberculosa adjuvant-induced uveitis.
    Mo JS; Streilein JW
    Ocul Immunol Inflamm; 2005; 13(2-3):139-47. PubMed ID: 16019673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-induced cell-mediated immune deviation to encephalitogenic antigens.
    Farooq SM; Ashour HM
    Brain Behav Immun; 2014 Jan; 35():64-9. PubMed ID: 24095895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD8+ T regulatory cells use a novel genetic program that includes CD103 to suppress Th1 immunity in eye-derived tolerance.
    Keino H; Masli S; Sasaki S; Streilein JW; Stein-Streilein J
    Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1533-42. PubMed ID: 16565389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapies based on principles of ocular immune privilege.
    Zhang-Hoover J; Stein-Streilein J
    Chem Immunol Allergy; 2007; 92():317-327. PubMed ID: 17264506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis.
    Crane IJ; Xu H; Wallace C; Manivannan A; Mack M; Liversidge J; Marquez G; Sharp PF; Forrester JV
    J Leukoc Biol; 2006 Mar; 79(3):435-43. PubMed ID: 16365158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.